Literature DB >> 21928103

Predictors associated with the willingness to take human papilloma virus vaccination.

Cho Naing1, Joanne Pereira, Tatsuki Abe, Daniel Eh Zhen Wei, Ibrizah Binti Abdul Rahman Bajera, Undugodage Heshan Kavinda Perera.   

Abstract

Human papilloma virus vaccine is considered to be the primary form of cervical cancer prevention. The objectives were (1) to determine knowledge about, and perception of human papilloma virus infection in relation to cervical cancer, (2) to explore the intention of the community to be vaccinated with human papilloma virus vaccine, and (3) to identify variables that could predict the likelihood of uptake of the vaccine. A cross-sectional survey was carried out in a semi-urban Town of Malaysia, using a pre-tested structured questionnaire. Summary statistics, Pearson chi-square test and a binary logistic regression were used for data analysis. A total of 232 respondents were interviewed. Overall, only a few had good knowledge related to human papilloma virus (14%) or vaccination (8%). Many had misconceptions that it could be transmitted through blood transfusion (57%). Sixty percent had intention to take vaccination. In the binary logistic model, willingness to take vaccination was significant with 'trusts that vaccination would be effective for prevention of cervical cancer' (P = 0.001), 'worries for themselves' (P < 0.001) or 'their family members' (P = 0.003) and 'being Indian ethnicity' (P = 0.024). The model could fairly predict the likelihood of uptake of the vaccine (Cox & Snell R(2) = .415; Nagelkerke R(2) = 0.561). Results indicate that intensive health education dispelling misconception and risk perception towards human papilloma virus infection and cervical cancer would be helpful to increase the acceptability of vaccination program.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21928103     DOI: 10.1007/s10900-011-9473-4

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  19 in total

Review 1.  Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.

Authors:  Edward P Armstrong
Journal:  J Manag Care Pharm       Date:  2010-04

Review 2.  Post-licensure monitoring of HPV vaccine in the United States.

Authors:  Lauri E Markowitz; Susan Hariri; Elizabeth R Unger; Mona Saraiya; S Deblina Datta; Eileen F Dunne
Journal:  Vaccine       Date:  2010-02-25       Impact factor: 3.641

3.  Human papillomavirus vaccination uptake and factors related to uptake in a traditional desert city in the United Arab Emirates.

Authors:  N S Al-Nuaimi; Y S Al-Ghas; A H Al-Owais; M Grivna; J Schneider; N J Nagelkerke; R M Bernsen
Journal:  Int J STD AIDS       Date:  2011-07       Impact factor: 1.359

4.  Social learning theory and the Health Belief Model.

Authors:  I M Rosenstock; V J Strecher; M H Becker
Journal:  Health Educ Q       Date:  1988

5.  Perceptions and opinions regarding human papilloma virus vaccination among young women in Malaysia.

Authors:  Redhwan Ahmed Al-Naggar; Karim Al-Jashamy; Robert Chen
Journal:  Asian Pac J Cancer Prev       Date:  2010

6.  Role of men in promoting the uptake of HPV vaccinations: focus groups' finding from a developing country.

Authors:  Li Ping Wong
Journal:  Int J Public Health       Date:  2009-09-22       Impact factor: 3.380

Review 7.  Predictors of HPV vaccine acceptability: a theory-informed, systematic review.

Authors:  Noel T Brewer; Karah I Fazekas
Journal:  Prev Med       Date:  2007-06-02       Impact factor: 4.018

8.  Parental intention to have daughters receive the human papillomavirus vaccine.

Authors:  Gina S Ogilvie; Valencia P Remple; Fawziah Marra; Shelly A McNeil; Monika Naus; Karen L Pielak; Thomas G Ehlen; Simon R Dobson; Deborah M Money; David M Patrick
Journal:  CMAJ       Date:  2007-12-04       Impact factor: 8.262

9.  Discriminatory attitudes and practices by health workers toward patients with HIV/AIDS in Nigeria.

Authors:  Chen Reis; Michele Heisler; Lynn L Amowitz; R Scott Moreland; Jerome O Mafeni; Chukwuemeka Anyamele; Vincent Iacopino
Journal:  PLoS Med       Date:  2005-07-19       Impact factor: 11.069

10.  Human papillomavirus infection in Honduran women with normal cytology.

Authors:  N Tábora; J M J E Bakkers; W G V Quint; L F A G Massuger; J A Matute; W J G Melchers; A Ferrera
Journal:  Cancer Causes Control       Date:  2009-08-15       Impact factor: 2.506

View more
  3 in total

1.  Acceptance of COVID-19 vaccines among college students: a study of the attitudes, knowledge, and willingness of students to vaccinate.

Authors:  Ning Jiang; Pengfei Gu; Ke Liu; Na Song; Xiaolian Jiang
Journal:  Hum Vaccin Immunother       Date:  2022-01-21       Impact factor: 3.452

2.  Awareness of human papillomavirus infection complications, cervical cancer, and vaccine among the Saudi population. A cross-sectional survey.

Authors:  Mazen M Almehmadi; Magdi M Salih; Ayman S Al-Hazmi
Journal:  Saudi Med J       Date:  2019-06       Impact factor: 1.484

3.  Challenges of health promotion and education strategies to prevent cervical cancer in India: A systematic review.

Authors:  Jissa Vinoda Thulaseedharan; Kirstin Grosse Frie; Rengaswamy Sankaranarayanan
Journal:  J Educ Health Promot       Date:  2019-11-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.